Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Articles

Pages

13951 items
1:31 PM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Acorda loses Amprya appeal, reports Inbrija PDUFA delay

Acorda Therapeutics Inc. (NASDAQ:ACOR) fell $10.30 (37%) to $17.25 the week of Sept. 10 following setbacks related to multiple sclerosis drug Ampyra dalfampridine and Parkinson's disease candidate Inbrija levodopa inhalation powder (CVT-301). On Sept. 10,...
12:49 PM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Telo, GSK targeting TERT to halt glioblastoma cell immortality

Telo Therapeutics Inc. (San Francisco, Calif.) is exploiting a partnership with GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to discover small molecules against an isoform of GABPB1, first identified as a cancer immortality target in a paper published...
10:27 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Takeda to move U.S. headquarters to Boston area

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will move its U.S. headquarters from Deerfield, Ill., to a to-be-determined site in the greater Boston area after its planned acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) closes next half. Takeda spokesperson...
10:26 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Patient groups urge CVS to reconsider ICER-restricted formulary

At least 94 patient groups and individuals signed a letter urging CVS Health Corp. (NYSE:CVS) President and CEO Larry Merlo to reconsider a new formulary that would be restricted to drugs deemed cost effective by...
10:24 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Sanofi creating China/emerging markets and primary care units

Sanofi (Euronext:SAN; NYSE:SNY) said it will create two new global business units early next year, one focused on China and emerging markets and the other on primary care. The China and emerging markets unit will be...
10:24 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Community cancer play OneOncology launches with $200M from General Atlantic

OneOncology Inc. (Nashville, Tenn.) launched on Sept. 12, backed with more than $200 million from General Atlantic that the newco will use to develop a data and technology platform to support community-based cancer care. On a...
6:04 AM, Sep 14, 2018  |  BC Week In Review | Company News  |  Other News

Juno paying $24M to settle JCAR015 class action suit

The Juno Therapeutics Inc. subsidiary of Celgene Corp. (NASDAQ:CELG) and three of its executive officers will pay stockholders $24 million to settle a class action suit related to discontinued CAR T cell therapy JCAR015. Under the...
3:44 PM, Sep 13, 2018  |  BC Week In Review | Company News  |  Other News

AI healthcare companies forming an alliance

Artificial intelligence healthcare companies are forming an alliance to advance and guide the use of AI in healthcare and drug development. The Alliance for Artificial Intelligence in Healthcare (AAIH) will act as the industry's advocate...
3:43 PM, Sep 13, 2018  |  BC Week In Review | Company News  |  Other News

Gottlieb rebukes Nostrum's 300% price hike for generic antibiotic

A price hike of more than 300% by Nostrum Pharmaceuticals LLC (New Brunswick, N.J.) for a 65-year-old antibiotic met swift condemnation by FDA Commissioner Scott Gottlieb on Sept. 11. Gottlieb said in a tweet that FDA...
12:58 PM, Sep 07, 2018  |  BC Week In Review | Company News  |  Other News

Akcea cutting workforce by 10% after Waylivra CRL

Akcea Therapeutics Inc. (NASDAQ:AKCA) will reduce its workforce by about 10% following receipt of a complete response letter from FDA for Waylivra volanesorsen to treat familial chylomicronemia syndrome (FCS). Akcea announced the CRL on Aug....

Pages